Selected research
Industry Growth & Trends
Global Extended-release Medication Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Extended-release Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Extended-release Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Extended-release Medication is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Extended-release Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Extended-release Medication market include Shanghai Shyndec Pharmaceutical, Takeda, Sanofi, Zhuhai Rundu Pharmaceutical, Johnson & Johnson, Novartis, Pfizer, Bayer and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Extended-release Medication market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Extended-release Medication market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Extended-release Medication market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Extended-release Medication.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Extended-release Medication market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Extended-release Medication Market by Company
Shanghai Shyndec Pharmaceutical
Takeda
Sanofi
Zhuhai Rundu Pharmaceutical
Johnson & Johnson
Novartis
Pfizer
Bayer
AbbVie
AstraZeneca
Endo Pharmaceuticals
Collegium Pharmaceutical, Inc
China Res Double-Crane
Extended-release Medication Segment by Type
Original Medication
Generic Medication
Extended-release Medication Segment by Application
Hospital
Drugstore
Other
Extended-release Medication Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Extended-release Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Extended-release Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Extended-release Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Extended-release Medication companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Original Medication
- Generic Medication
Applications
- Hospital
- Drugstore
- Other
Companies covered
- Shanghai Shyndec Pharmaceutical
- Takeda
- Sanofi
- Zhuhai Rundu Pharmaceutical
- Johnson & Johnson
- Novartis
- Pfizer
- Bayer
- AbbVie
- AstraZeneca
- Endo Pharmaceuticals
- Collegium Pharmaceutical, Inc
- China Res Double-Crane
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Extended-release Medication Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Extended-release Medication Market Size by Region (2021-2032)
- 1.4.1 Global Extended-release Medication Market Size by Region (2021-2026)
- 1.4.2 Global Extended-release Medication Market Size by Region (2027-2032)
- 1.5 Key Regions Extended-release Medication Market Size (2021-2032)
- 1.5.1 North America Extended-release Medication Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Extended-release Medication Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Extended-release Medication Market Size Growth Rate (2021-2032)
- 1.5.4 South America Extended-release Medication Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Extended-release Medication Market Size Growth Rate (2021-2032)
2 Extended-release Medication Market by Type
- 2.1 Type Introduction
- 2.1.1 Original Medication
- 2.1.2 Generic Medication
- 2.2 Global Extended-release Medication Market Size by Type
- 2.2.1 Global Extended-release Medication Market Size Overview by Type (2021-2032)
- 2.2.2 Global Extended-release Medication Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Extended-release Medication Market Size Forecasted by Type (2027-2032)
- 2.3 Global Extended-release Medication Market Size by Regions
- 2.3.1 North America Extended-release Medication Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Extended-release Medication Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Extended-release Medication Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Extended-release Medication Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Extended-release Medication Market Size Breakdown by Type (2021-2026)
3 Extended-release Medication Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Drugstore
- 3.1.3 Other
- 3.2 Global Extended-release Medication Market Size by Application
- 3.2.1 Global Extended-release Medication Market Size Overview by Application (2021-2032)
- 3.2.2 Global Extended-release Medication Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Extended-release Medication Market Size Forecasted by Application (2027-2032)
- 3.3 Global Extended-release Medication Market Size by Regions
- 3.3.1 North America Extended-release Medication Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Extended-release Medication Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Extended-release Medication Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Extended-release Medication Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Extended-release Medication Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Extended-release Medication Industry Trends
- 4.2 Extended-release Medication Industry Drivers
- 4.3 Extended-release Medication Industry Opportunities and Challenges
- 4.4 Extended-release Medication Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Extended-release Medication Revenue (2021-2026)
- 5.2 Global Extended-release Medication Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Extended-release Medication Key Company Headquarters & Area Served
- 5.4 Global Extended-release Medication Company, Product Type & Application
- 5.5 Global Extended-release Medication Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Extended-release Medication Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Extended-release Medication Players Market Share by Revenue in 2025
- 5.6.3 2025 Extended-release Medication Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Shanghai Shyndec Pharmaceutical
- 6.1.1 Shanghai Shyndec Pharmaceutical Company Information
- 6.1.2 Shanghai Shyndec Pharmaceutical Business Overview
- 6.1.3 Shanghai Shyndec Pharmaceutical Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Shanghai Shyndec Pharmaceutical Extended-release Medication Product Portfolio
- 6.1.5 Shanghai Shyndec Pharmaceutical Recent Developments
- 6.2 Takeda
- 6.2.1 Takeda Company Information
- 6.2.2 Takeda Business Overview
- 6.2.3 Takeda Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Takeda Extended-release Medication Product Portfolio
- 6.2.5 Takeda Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sanofi Extended-release Medication Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 Zhuhai Rundu Pharmaceutical
- 6.4.1 Zhuhai Rundu Pharmaceutical Company Information
- 6.4.2 Zhuhai Rundu Pharmaceutical Business Overview
- 6.4.3 Zhuhai Rundu Pharmaceutical Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Zhuhai Rundu Pharmaceutical Extended-release Medication Product Portfolio
- 6.4.5 Zhuhai Rundu Pharmaceutical Recent Developments
- 6.5 Johnson & Johnson
- 6.5.1 Johnson & Johnson Company Information
- 6.5.2 Johnson & Johnson Business Overview
- 6.5.3 Johnson & Johnson Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Johnson & Johnson Extended-release Medication Product Portfolio
- 6.5.5 Johnson & Johnson Recent Developments
- 6.6 Novartis
- 6.6.1 Novartis Company Information
- 6.6.2 Novartis Business Overview
- 6.6.3 Novartis Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Novartis Extended-release Medication Product Portfolio
- 6.6.5 Novartis Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Pfizer Extended-release Medication Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Bayer
- 6.8.1 Bayer Company Information
- 6.8.2 Bayer Business Overview
- 6.8.3 Bayer Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Bayer Extended-release Medication Product Portfolio
- 6.8.5 Bayer Recent Developments
- 6.9 AbbVie
- 6.9.1 AbbVie Company Information
- 6.9.2 AbbVie Business Overview
- 6.9.3 AbbVie Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 AbbVie Extended-release Medication Product Portfolio
- 6.9.5 AbbVie Recent Developments
- 6.10 AstraZeneca
- 6.10.1 AstraZeneca Company Information
- 6.10.2 AstraZeneca Business Overview
- 6.10.3 AstraZeneca Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 AstraZeneca Extended-release Medication Product Portfolio
- 6.10.5 AstraZeneca Recent Developments
- 6.11 Endo Pharmaceuticals
- 6.11.1 Endo Pharmaceuticals Company Information
- 6.11.2 Endo Pharmaceuticals Business Overview
- 6.11.3 Endo Pharmaceuticals Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Endo Pharmaceuticals Extended-release Medication Product Portfolio
- 6.11.5 Endo Pharmaceuticals Recent Developments
- 6.12 Collegium Pharmaceutical, Inc
- 6.12.1 Collegium Pharmaceutical, Inc Company Information
- 6.12.2 Collegium Pharmaceutical, Inc Business Overview
- 6.12.3 Collegium Pharmaceutical, Inc Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Collegium Pharmaceutical, Inc Extended-release Medication Product Portfolio
- 6.12.5 Collegium Pharmaceutical, Inc Recent Developments
- 6.13 China Res Double-Crane
- 6.13.1 China Res Double-Crane Company Information
- 6.13.2 China Res Double-Crane Business Overview
- 6.13.3 China Res Double-Crane Extended-release Medication Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 China Res Double-Crane Extended-release Medication Product Portfolio
- 6.13.5 China Res Double-Crane Recent Developments
7 North America
- 7.1 North America Extended-release Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Extended-release Medication Market Size by Country (2021-2026)
- 7.3 North America Extended-release Medication Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Extended-release Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Extended-release Medication Market Size by Country (2021-2026)
- 8.3 Europe Extended-release Medication Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Extended-release Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Extended-release Medication Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Extended-release Medication Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Extended-release Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Extended-release Medication Market Size by Country (2021-2026)
- 10.3 South America Extended-release Medication Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Extended-release Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Extended-release Medication Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Extended-release Medication Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst